545 related articles for article (PubMed ID: 33154284)
1. Efficacy of nifedipine versus hydralazine in the management of severe hypertension in pregnancy: A randomised controlled trial.
Adebayo JA; Nwafor JI; Lawani LO; Esike CO; Olaleye AA; Adiele NA
Niger Postgrad Med J; 2020; 27(4):317-324. PubMed ID: 33154284
[TBL] [Abstract][Full Text] [Related]
2. Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial.
Sharma C; Soni A; Gupta A; Verma A; Verma S
Am J Obstet Gynecol; 2017 Dec; 217(6):687.e1-687.e6. PubMed ID: 28867601
[TBL] [Abstract][Full Text] [Related]
3. Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials.
Wu HZ; Cheng Y; Yu D; Li JB; Jiang YF; Zhu ZN
Hypertens Pregnancy; 2022 May; 41(2):126-138. PubMed ID: 35361052
[TBL] [Abstract][Full Text] [Related]
4. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
Firoz T; Magee LA; MacDonell K; Payne BA; Gordon R; Vidler M; von Dadelszen P;
BJOG; 2014 Sep; 121(10):1210-8; discussion 1220. PubMed ID: 24832366
[TBL] [Abstract][Full Text] [Related]
5. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
Easterling T; Mundle S; Bracken H; Parvekar S; Mool S; Magee LA; von Dadelszen P; Shochet T; Winikoff B
Lancet; 2019 Sep; 394(10203):1011-1021. PubMed ID: 31378394
[TBL] [Abstract][Full Text] [Related]
6. Comparing Intravenous Labetalol and Intravenous Hydralazine for Managing Severe Gestational Hypertension.
Ehikioya E; Okobi OE; Beeko MAE; Abanga R; Abah NNI; Briggs L; Nwimo PN; Beeko PKA; Nwachukwu OB; Okoroafor CC
Cureus; 2023 Jul; 15(7):e42332. PubMed ID: 37614273
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy of nifedipine and hydralazine in hypertensive crisis in pregnancy.
Rezaei Z; Sharbaf FR; Pourmojieb M; Youefzadeh-Fard Y; Motevalian M; Khazaeipour Z; Esmaeili S
Acta Med Iran; 2011; 49(11):701-6. PubMed ID: 22131238
[TBL] [Abstract][Full Text] [Related]
8. Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial.
Shekhar S; Sharma C; Thakur S; Verma S
Obstet Gynecol; 2013 Nov; 122(5):1057-1063. PubMed ID: 24104790
[TBL] [Abstract][Full Text] [Related]
9. Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
Sridharan K; Sequeira RP
Br J Clin Pharmacol; 2018 Sep; 84(9):1906-1916. PubMed ID: 29974489
[TBL] [Abstract][Full Text] [Related]
10. PP088. Oral antihypertensive therapy for severe hypertension in pregnancy.
Firoz T; Magee LA; Lalani S; Sawchuck D; Payne B; Vidler M; Gordon R; von Dadelszen P;
Pregnancy Hypertens; 2012 Jul; 2(3):288. PubMed ID: 26105410
[TBL] [Abstract][Full Text] [Related]
11. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial.
Raheem IA; Saaid R; Omar SZ; Tan PC
BJOG; 2012 Jan; 119(1):78-85. PubMed ID: 21985500
[TBL] [Abstract][Full Text] [Related]
12. IV labetalol and oral nifedipine in acute control of severe hypertension in pregnancy-A randomized controlled trial.
Zulfeen M; Tatapudi R; Sowjanya R
Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():46-52. PubMed ID: 30878897
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial.
S D; Novri DA; Hamidy Y; Savira M
F1000Res; 2022; 11():1287. PubMed ID: 37273965
[No Abstract] [Full Text] [Related]
14. Identification of factors associated with delayed treatment of obstetric hypertensive emergencies.
Kantorowska A; Heiselman CJ; Halpern TA; Akerman MB; Elsayad A; Muscat JC; Sicuranza GB; Vintzileos AM; Heo HJ
Am J Obstet Gynecol; 2020 Aug; 223(2):250.e1-250.e11. PubMed ID: 32067968
[TBL] [Abstract][Full Text] [Related]
15. Pulse pressure as a predictor of response to treatment for severe hypertension in pregnancy.
Mullan SJ; Vricella LK; Edwards AM; Powel JE; Ong SK; Li X; Tomlinson TM
Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100455. PubMed ID: 34375751
[TBL] [Abstract][Full Text] [Related]
16. The flipside of hydralazine in pregnancy: A systematic review and meta-analysis.
Antza C; Dimou C; Doundoulakis I; Akrivos E; Stabouli S; Haidich AB; Goulis DG; Kotsis V
Pregnancy Hypertens; 2020 Jan; 19():177-186. PubMed ID: 32044579
[TBL] [Abstract][Full Text] [Related]
17. Intravenous labetalol versus oral nifedipine for acute hypertension in pregnancy: effects on cerebral perfusion pressure.
Tolcher MC; Fox KA; Sangi-Haghpeykar H; Clark SL; Belfort MA
Am J Obstet Gynecol; 2020 Sep; 223(3):441.e1-441.e8. PubMed ID: 32544404
[TBL] [Abstract][Full Text] [Related]
18. Comparison of intravenous labetalol and hydralazine for severe hypertension in pregnancy in Northeastern Nigeria: A randomized controlled trial.
Muhammad S; Usman H; Dawha YM; Yahya A; Yekeen A; Bako B
Pregnancy Hypertens; 2022 Aug; 29():1-6. PubMed ID: 35605426
[TBL] [Abstract][Full Text] [Related]
19. The effect of labetalol and nifedipine MR on blood pressure in women with chronic hypertension in pregnancy.
Shawkat E; Mistry H; Chmiel C; Webster L; Chappell L; Johnstone ED; Myers JE
Pregnancy Hypertens; 2018 Jan; 11():92-98. PubMed ID: 29523282
[TBL] [Abstract][Full Text] [Related]
20. A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial.
Hennessy A; Thornton CE; Makris A; Ogle RF; Henderson-Smart DJ; Gillin AG; Child A
Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):279-85. PubMed ID: 17627681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
